Pacira Pharma (PCRX) Tops Q2 EPS by 16c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira Pharma (PCRX) Tops Q2 EPS by 16c

Pacira Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results

August 4, 2016 7:30 AM EDT

-- Total Net Revenues Up 18% Year-Over-Year ---- EXPAREL® Net Product Sales Up 15% Year-Over-Year ---- Conference Call Today at 9 a.m. ET --

PARSIPPANY, N.J., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today provided updates on EXPAREL® (bupivacaine liposome injectable suspension) for postsurgical pain in the United States and announced consolidated financial results for the... More